Article citationsMore>>

J. S. Lee, K. Park, S. Kim, et al., “A Randomized Phase III Study of Gefitinib (IRESSATM) versus Standard Chemotherapy (Gemcitabine Plus Cisplatin) as First-Line Treatment for Never Skmokers with Advanced or Metastatic Adenocarcinoma of the Lung,” Journal of Thoracic Oncology, Vol. 4, No. 9, 2009, p. S283.

has been cited by the following article:

Follow SCIRP
Twitter Facebook Linkedin Weibo
Contact us
+1 323-425-8868
customer@scirp.org
WhatsApp +86 18163351462(WhatsApp)
Click here to send a message to me 1655362766
Paper Publishing WeChat
Free SCIRP Newsletters
Copyright © 2006-2024 Scientific Research Publishing Inc. All Rights Reserved.
Top